QI
ABBV icon

Qtron Investments’s AbbVie ABBV Stock Holding History

Qtron Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.49M Sell
17,841
-2,229
-11% -$480K 0.6% 28
2026
Q1 		$4.37M Buy
20,070
+5
+0% +$1.11K 0.59% 23
2025
Q4 		$4.58M Sell
20,065
-2,854
-12% -$650K 0.6% 22
2025
Q3 		$5.31M Buy
22,919
+860
+4% +$175K 0.66% 21
2025
Q2 		$4.09M Hold
22,059
– – 0.52% 25
2025
Q1 		$4.62M Buy
22,059
+624
+3% +$121K 0.69% 22
2024
Q4 		$3.81M Hold
21,435
– – 0.53% 25
2024
Q3 		$4.23M Hold
21,435
– – 0.58% 26
2024
Q2 		$3.68M Sell
21,435
-904
-4% -$150K 0.53% 26
2024
Q1 		$4.07M Buy
22,339
+765
+4% +$132K 0.58% 27
2023
Q4 		$3.34M Buy
21,574
+650
+3% +$94.8K 0.55% 31
2023
Q3 		$3.12M Buy
20,924
+782
+4% +$115K 0.59% 32
2023
Q2 		$2.71M Buy
20,142
+1,693
+9% +$248K 0.52% 43
2023
Q1 		$2.94M Buy
18,449
+186
+1% +$28.4K 0.6% 34
2022
Q4 		$2.95M Buy
18,263
+2,329
+15% +$357K 0.62% 29
2022
Q3 		$2.14M Sell
15,934
-4,890
-23% -$702K 0.53% 34
2022
Q2 		$3.19M Buy
20,824
+1,480
+8% +$226K 0.7% 23
2022
Q1 		$3.14M Buy
19,344
+4,823
+33% +$701K 0.7% 25
2021
Q4 		$1.97M Hold
14,521
– – 0.44% 50
2021
Q3 		$1.57M Buy
14,521
+1,428
+11% +$163K 0.42% 52
2021
Q2 		$1.48M Hold
13,093
– – 0.37% 52
2021
Q1 		$1.42M Hold
13,093
– – 0.4% 55
2020
Q4 		$1.4M Buy
13,093
+1,673
+15% +$161K 0.38% 53
2020
Q3 		$1M Hold
11,420
– – 0.35% 60
2020
Q2 		$1.12M Sell
11,420
-544
-5% -$47.9K 0.45% 44
2020
Q1 		$912K Buy
11,964
+2,834
+31% +$241K 0.55% 46
2019
Q4 		$808K Buy
+9,130
New +$758K 0.47% 68

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Qtron Investments's ABBV Position: Q2 2026 in Review

Qtron Investments reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $480K and leaving 17,841 shares worth $4.49M. The position accounts for 0.6% of the portfolio, ranked #28.

Qtron Investments first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.31M in Q3 2025. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Qtron Investments held 17,841 shares of AbbVie worth $4.49M as of Q2 2026.
  • Qtron Investments sold 2,229 AbbVie shares in Q2 2026, an estimated $480K.
  • AbbVie made up 0.6% of Qtron Investments's portfolio in Q2 2026, its #28 holding.
  • Qtron Investments first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Qtron Investments's AbbVie position peaked at $5.31M in Q3 2025.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.